Immediate Impact

4 from Science/Nature 63 standout
Sub-graph 1 of 21

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Dual-Site Biomimetic Cu/Zn-MOF for Atopic Dermatitis Catalytic Therapy via Suppressing FcγR-Mediated Phagocytosis
2024 Standout
3 intermediate papers

Works of Niranjan Rao being referenced

The oral Janus kinase/spleen tyrosine kinase inhibitorASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study
2019
Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis
2019

Author Peers

Author Last Decade Papers Cites
Niranjan Rao 149 78 95 192 162 26 832
Eduardo E. Valdez-Moráles 217 187 23 77 75 24 865
Raquel Guerrero‐Alba 203 182 18 74 75 31 896
Anne-Marie Coelho 99 12 62 53 40 21 738
Mark Watling 210 37 17 85 141 28 946
Tor Skärby 302 49 67 20 28 34 947
Dan Li 144 82 18 31 67 50 681
Alyssa K. Kosturakis 175 428 29 90 78 17 981
James Hilbert 105 116 17 42 83 37 700
Anita Chamba 253 88 35 17 24 19 738
Robert J. Capetola 223 35 18 133 176 40 824

All Works

Loading papers...

Rankless by CCL
2026